AbbVie (ABBV) said Friday that the U.S. FDA has approved a supplemental new drug application for its combination regimen of Venclexta (venetoclax) and acalabrutinib to treat previously untreated ...
The FDA approved acalabrutinib (Calquence) plus venetoclax (Venclexta) for previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma as the first all-oral, fixed-duration ...
The FDA has approved oral acalabrutinib (Calquence, AstraZeneca) in combination with venetoclax (Venclexta, AbbVie and Genentech) for the first-line treatment of adults with chronic lymphocytic ...
On Tuesday, February 17, 2026, A. Patsy Fabiano II, of Holland, passed away at the age of 81. A. Patsy Fabiano II was born August 22nd, 1944, to Joseph and Lucille Fabiano in Holland, Michigan. He ...
FDA cleared acalabrutinib plus venetoclax as the only all-oral, fixed-dose combination option for first-line, treatment-naïve CLL/SLL. Phase 3 AMPLIFY showed superior PFS versus chemoimmunotherapy, ...
Chronic lymphocytic leukemia (CLL), is a type of cancer that affects a type of white blood cell in your body called a lymphocyte. White blood cells are made in your bone marrow and help your body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results